← Eichor
Study identifier: NCT05744310 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Effects of Long Term Ventilation Support on the Quality of Life of ALS Patients and Their Families

Condition: Amyotrophic Lateral Sclerosis · Motor Neuron Disease · Nervous System Diseases  ·  Sponsor: Haukeland University Hospital

PhaseNA
Planned participants200
Who can joinAll sexes, 8 Years to no upper limit
Healthy volunteersYes

About this study

Amyotrophic lateral sclerosis (ALS) is a serious rapidly progressive disease of the nervous system. The average survival from the time of diagnosis is two to three years. The patient physical and psychological sufferings in ALS are immense, and apart from Riluzole, there is no effective treatment. Care of advanced ALS have an estimated cost of 4-8 million NOK per year. Perhaps the most challenging topic of ALS care is the decision to extend ventilation support into the stages of disease that require treatment both during day and night. In these cases, treatment is clearly life-sustaining and although quality of life may be maintained, the burden of caregiving imposed upon family or health care workers is huge, regardless of tracheostomy (TIV) or non-invasive (NIV) modality. The present study is a longitudinal questionnaire study in Norway measuring overall quality of life, health-related quality of life, and disease-specific quality of life in ALS patients, partners and children before and after the introduction of life sustaining ventilation support. The investigators aim to increase the knowledge on how life-sustaining ventilation support with NIV or TIV affects the quality of life in ALS patients, life partners and children. The results from the study may provide crucial information for clinicians and patients on one of the most difficult ethical issues of ALS treatment. The investigators anticipate that this information will facilitate a shared decision making processes,…

This description comes directly from the study's public registry record.

Talk to the study team

Ole-Bjørn Tysnes  ·  + 47 55975063  ·  ole-bjorn.tysnes@helse-bergen.no

Tale Litlere Bjerknes  ·  +47 55975045  ·  tale.litlere.bjerknes@helse-bergen.no

Always discuss trial participation with your own doctor first.

Locations (9)

Nordland Hospital BodøBodø, Nordland, NorwayRecruiting
Sørlandet Hospital TrustKristiansand, Vest Agder, NorwayRecruiting
Haukeland University HospitalBergen, NorwayRecruiting
Akershus University HospitalLørenskog, NorwayRecruiting
Oslo University HospitalOslo, NorwayRecruiting
Østfold Hospital KalnesSarpsborg, NorwayNot Yet Recruiting
Stavanger University HospitalStavanger, NorwayRecruiting
Universitetssykehuset Nord-NorgeTromsø, NorwayRecruiting
St. Olavs HospitalTrondheim, NorwayRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05744310